On June 14, the Montpellier Cancer Institute inaugurated one of the first MRI-guided radiation therapy machines in France. This innovative technology improves cancer treatment and boosts research in an area already known for its excellence in the field.
Targeting an innovative artificial intelligence program, Suni-ART
MRI-guided radiation therapy represents an investment of €8.9 million, co-funded by the French government and Montpellier Méditerranée Métropole, with support from the Occitanie Region, Hérault Department Council, and ICM. This approach paves the way for several major national clinical research projects driven by ICM with the Paoli Calmettes Institute (Marseille), Georges-François Leclerc Center (Dijon), and internationally with University of Heidelberg and VU Medical Center (Amsterdam). ICM also plans to develop an innovative artificial intelligence program for radiation therapy called Suni-ART, as part of a large international hospital and university consortium that includes startup companies, notably from Montpellier. With these projects, ICM confirms its innovation momentum and leading position in oncology radiation therapy both in France and internationally.There are 0 commentaires on this page
Leave a comment